People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IVIEW Therapeutics, Inc. | — | Pharmaceuticals | Series B | $39.2M | $67.7M | 2021 |
Qi Zhu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Qi Zhu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wei Wang | 1 | 7 |
| Houman Hemmati | 1 | 4 |
| Jingjie Li | 1 | 1 |
| Xiaolu Sun | 1 | 1 |
| Bo Liang | 1 | 1 |
| Bin He | 1 | 1 |
| Tom Tao Du | 1 | 1 |
| John J Baldwin | 1 | 1 |
| Xiaolu Tao Sun | 1 | 1 |
| Bin Tao He | 1 | 1 |
| Xiaolu J Sun | 1 | 1 |
| Bin J He | 1 | 1 |
| Tao J Du | 1 | 1 |
| Jun J Du | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.